MitraClip™ implantation plus left atrial appendage occlusion in a hereditary hemorrhagic telangiectasia patient.
Pasquale D'AlessandroRocco TrittoEmanuela De CillisTommaso AcquavivaArturo GiordanoPalma L NestolaMartino PepeAlessandro S BortonePublished in: Future cardiology (2022)
Hereditary hemorrhagic telangiectasia is regarded as a high hemorrhagic risk condition, and the management of anticoagulation and heart surgery in these patients can be challenging. The authors describe a combined percutaneous treatment of mitral regurgitation and left atrial appendage occlusion in a patient affected by hereditary hemorrhagic telangiectasia and atrial fibrillation, supporting the safety and feasibility of the procedure and the optimal short-term outcome.
Keyphrases
- left atrial appendage
- atrial fibrillation
- catheter ablation
- minimally invasive
- left atrial
- oral anticoagulants
- direct oral anticoagulants
- heart failure
- case report
- ejection fraction
- newly diagnosed
- percutaneous coronary intervention
- venous thromboembolism
- patient reported outcomes
- coronary artery disease
- coronary artery bypass
- replacement therapy